Eli Lilly (LLY) closed the most recent trading day at $1,027.51, moving +1.8% from the previous trading session. This change outpaced the S&P 500's 1.07% loss on the day. At the same time, the Dow ...
Eli Lilly (LLY) shares spiked ~3% on Thursday after the obesity drugmaker posted Phase 3 data showing its next-gen therapy retatrutide can generate up to 24% of weight loss, a “best-in-class" efficacy ...
Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound. The ...
Day 1. We're thrilled today to -- my name is Geoff Meacham. I'm the senior biopharma analyst, and my team is in the audience as well. So we're thrilled today to have Ilya Yuffa, who is EVP and ...
Eli Lilly and Co (NYSE: LLY) on Thursday shared topline results from the Phase 3 TRIUMPH-4 trial evaluating the two highest investigational doses of retatrutide. Retatrutide is a GIP, GLP-1, and ...
Hosted on MSN
Eli Lilly (LLY) stock is up, what you need to know
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the morning session after the company announced highly positive Phase 3 trial results for its next-generation weight loss ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. From late 2020 to the summer of 2024, Eli Lilly & Co.
Hosted on MSN
Eli Lilly Stock (LLY) Rose 30% in November
Shares of Eli Lilly & Co. (LLY), the world’s biggest pharmaceutical concern, rose 30.77% during November, making the stock a top performer in the benchmark S&P 500 index. Claim 60% off TipRanks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback